Literature DB >> 30651367

Residues on Adeno-associated Virus Capsid Lumen Dictate Interactions and Compatibility with the Assembly-Activating Protein.

Anna C Maurer1,2, Ana Karla Cepeda Diaz1,2, Luk H Vandenberghe3,2,4,5.   

Abstract

The adeno-associated virus (AAV) serves as a broadly used vector system for in vivo gene delivery. The process of AAV capsid assembly remains poorly understood. The viral cofactor assembly-activating protein (AAP) is required for maximum AAV production and has multiple roles in capsid assembly, namely, trafficking of the structural proteins (VP) to the nuclear site of assembly, promoting the stability of VP against multiple degradation pathways, and facilitating stable interactions between VP monomers. The N-terminal 60 amino acids of AAP (AAPN) are essential for these functions. Presumably, AAP must physically interact with VP to execute its multiple functions, but the molecular nature of the AAP-VP interaction is not well understood. Here, we query how structurally related AAVs functionally engage AAP from AAV serotype 2 (AAP2) toward virion assembly. These studies led to the identification of key residues on the lumenal capsid surface that are important for AAP-VP and for VP-VP interactions. Replacing a cluster of glutamic acid residues with a glutamine-rich motif on the conserved VP beta-barrel structure of variants incompatible with AAP2 creates a gain-of-function mutant compatible with AAP2. Conversely, mutating positively charged residues within the hydrophobic region of AAP2 and conserved core domains within AAPN creates a gain-of-function AAP2 mutant that rescues assembly of the incompatible variant. Our results suggest a model for capsid assembly where surface charge/neutrality dictates an interaction between AAPN and the lumenal VP surface to nucleate capsid assembly.IMPORTANCE Efforts to engineer the AAV capsid to gain desirable properties for gene therapy (e.g., tropism, reduced immunogenicity, and higher potency) require that capsid modifications do not affect particle assembly. The relationship between VP and the cofactor that facilitates its assembly, AAP, is central to both assembly preservation and vector production. Understanding the requirements for this compatibility can inform manufacturing strategies to maximize production and reduce costs. Additionally, library-based approaches that simultaneously examine a large number of capsid variants would benefit from a universally functional AAP, which could hedge against overlooking variants with potentially valuable phenotypes that were lost during vector library production due to incompatibility with the cognate AAP. Studying interactions between the structural and nonstructural components of AAV enhances our fundamental knowledge of capsid assembly mechanisms and the protein-protein interactions required for productive assembly of the icosahedral capsid.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  AAP; AAV; adeno-associated virus; ancestral sequence reconstruction; assembly-activating protein; capsid assembly; gene therapy; protein-protein interactions; vector engineering

Mesh:

Substances:

Year:  2019        PMID: 30651367      PMCID: PMC6430561          DOI: 10.1128/JVI.02013-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  AAV-ID: A Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations.

Authors:  Simon Pacouret; Mohammed Bouzelha; Rajani Shelke; Eva Andres-Mateos; Ru Xiao; Anna Maurer; Mathieu Mevel; Heikki Turunen; Trisha Barungi; Magalie Penaud-Budloo; Frédéric Broucque; Véronique Blouin; Philippe Moullier; Eduard Ayuso; Luk H Vandenberghe
Journal:  Mol Ther       Date:  2017-04-17       Impact factor: 11.454

2.  Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.

Authors:  Lauriel F Earley; John M Powers; Kei Adachi; Joshua T Baumgart; Nancy L Meyer; Qing Xie; Michael S Chapman; Hiroyuki Nakai
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

3.  The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes.

Authors:  F Sonntag; K Köther; K Schmidt; M Weghofer; C Raupp; K Nieto; A Kuck; B Gerlach; B Böttcher; O J Müller; K Lux; M Hörer; J A Kleinschmidt
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

4.  Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.

Authors:  Narendra Maheshri; James T Koerber; Brian K Kaspar; David V Schaffer
Journal:  Nat Biotechnol       Date:  2006-01-22       Impact factor: 54.908

5.  Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus.

Authors:  Florian Sonntag; Svenja Bleker; Barbara Leuchs; Roger Fischer; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

6.  Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein.

Authors:  J P Trempe; B J Carter
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

7.  Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.

Authors:  Xuan Shen; Terry Storm; Mark A Kay
Journal:  Mol Ther       Date:  2007-08-28       Impact factor: 11.454

8.  Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.

Authors:  Wuping Li; Aravind Asokan; Zhijian Wu; Terry Van Dyke; Nina DiPrimio; Jarrod S Johnson; Lakshmanan Govindaswamy; Mavis Agbandje-McKenna; Stefan Leichtle; D Eugene Redmond; Thomas J McCown; Kimberly B Petermann; Norman E Sharpless; Richard J Samulski
Journal:  Mol Ther       Date:  2008-05-20       Impact factor: 11.454

9.  Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.

Authors:  Kenneth H Warrington; Oleg S Gorbatyuk; Jeffrey K Harrison; Shaun R Opie; Sergei Zolotukhin; Nicholas Muzyczka
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  VIPERdb2: an enhanced and web API enabled relational database for structural virology.

Authors:  Mauricio Carrillo-Tripp; Craig M Shepherd; Ian A Borelli; Sangita Venkataraman; Gabriel Lander; Padmaja Natarajan; John E Johnson; Charles L Brooks; Vijay S Reddy
Journal:  Nucleic Acids Res       Date:  2008-11-03       Impact factor: 16.971

View more
  5 in total

1.  The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation.

Authors:  Yang Zhan; Wanting Yu; Xiong Cai; Xinnuo Lei; Hongyu Lei; Aibing Wang; Yujie Sun; Naidong Wang; Zhibang Deng; Yi Yang
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

2.  Establishment of a Recombinant AAV2/HBoV1 Vector Production System in Insect Cells.

Authors:  Xuefeng Deng; Wei Zou; Ziying Yan; Jianming Qiu
Journal:  Genes (Basel)       Date:  2020-04-17       Impact factor: 4.096

3.  Adeno-associated virus capsid protein expression in Escherichia coli and chemically defined capsid assembly.

Authors:  Dinh To Le; Marco T Radukic; Kristian M Müller
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

4.  Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features.

Authors:  Mario Mietzsch; Ariana Jose; Paul Chipman; Nilakshee Bhattacharya; Nadia Daneshparvar; Robert McKenna; Mavis Agbandje-McKenna
Journal:  Viruses       Date:  2021-01-13       Impact factor: 5.818

Review 5.  Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry.

Authors:  Edward E Large; Mark A Silveria; Grant M Zane; Onellah Weerakoon; Michael S Chapman
Journal:  Viruses       Date:  2021-07-10       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.